CN Patent

CN102406621B — 用于治疗肝病的冻干粉针剂

Assigned to Xi'an Anjian Pharmaceutical Co ltd · Expires 2013-04-03 · 13y expired

What this patent protects

本发明提供了用于治疗肝病的冻干粉针剂。具体而言，所述冻干粉针剂包括以下式I化合物：和甘露醇，以及任选的pH调节剂，所述式I化合物与所述赋形剂的重量比为1∶0.2～1∶5。本发明还涉及所述冻干粉针剂的制备方法。本发明冻干粉针剂具有令人期待的药学上的优点。

USPTO Abstract

本发明提供了用于治疗肝病的冻干粉针剂。具体而言，所述冻干粉针剂包括以下式I化合物：和甘露醇，以及任选的pH调节剂，所述式I化合物与所述赋形剂的重量比为1∶0.2～1∶5。本发明还涉及所述冻干粉针剂的制备方法。本发明冻干粉针剂具有令人期待的药学上的优点。

Drugs covered by this patent

phenobarbital-sodium (PHENOBARBITAL SODIUM)

Patent Metadata

Patent number: CN102406621B
Jurisdiction: CN
Classification: —
Expires: 2013-04-03
Drug substance claim: No
Drug product claim: No
Assignee: Xi'an Anjian Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.